{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:02:02Z","timestamp":1794488522531,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801967"],"award-info":[{"award-number":["81801967"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The transcription coactivator YAP plays a vital role in Hippo pathway for organ-size control and tissue homeostasis. Recent studies have demonstrated YAP is closely related to immune disorders and inflammatory diseases, but the underlying mechanisms remain less defined. Here, we find that YAP promotes the activation of NLRP3 inflammasome, an intracellular multi-protein complex that orchestrates host immune responses to infections or sterile injuries. YAP deficiency in myeloid cells significantly attenuates LPS-induced systemic inflammation and monosodium urate (MSU) crystals-induced peritonitis. Mechanistically, YAP physically interacts with NLRP3 and maintains the stability of NLRP3 through blocking the association between NLRP3 and the E3 ligase \u03b2-TrCP1, the latter increases the proteasomal degradation of NLRP3 via K27-linked ubiquitination at lys380. Together, these findings establish a role of YAP in the activation of NLRP3 inflammasome, and provide potential therapeutic target to treat the NLRP3 inflammasome-related diseases.<\/jats:p>","DOI":"10.1038\/s41467-021-22987-3","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T06:04:54Z","timestamp":1620713094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":155,"title":["YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3"],"prefix":"10.1038","volume":"12","author":[{"given":"Dan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yening","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2560-9862","authenticated-orcid":false,"given":"Yue","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingmin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7921-8018","authenticated-orcid":false,"given":"Liping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-0406","authenticated-orcid":false,"given":"Ben","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3889-2118","authenticated-orcid":false,"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"22987_CR1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson, K. V., Deng, M. & Ting, J. P. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 19, 477\u2013489 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"22987_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","volume":"21","author":"H Guo","year":"2015","unstructured":"Guo, H., Callaway, J. B. & Ting, J. P. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat. Med. 21, 677\u2013687 (2015).","journal-title":"Nat. Med."},{"key":"22987_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821\u2013832 (2010).","journal-title":"Cell"},{"key":"22987_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1146\/annurev-immunol-031210-101405","volume":"29","author":"BK Davis","year":"2011","unstructured":"Davis, B. K., Wen, H. & Ting, J. P. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29, 707\u2013735 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"22987_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-cellbio-101011-155745","volume":"28","author":"M Lamkanfi","year":"2012","unstructured":"Lamkanfi, M. & Dixit, V. M. Inflammasomes and their roles in health and disease. Annu. Rev. Cell Dev. Biol. 28, 137\u2013161 (2012).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"22987_CR6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ni.2228","volume":"13","author":"H Wen","year":"2012","unstructured":"Wen, H., Ting, J. P. & O\u2019Neill, L. A. A role for the NLRP3 inflammasome in metabolic diseases\u2013did Warburg miss inflammation? Nat. Immunol. 13, 352\u2013357 (2012).","journal-title":"Nat. Immunol."},{"key":"22987_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ni.3772","volume":"18","author":"IS Afonina","year":"2017","unstructured":"Afonina, I. S., Zhong, Z., Karin, M. & Beyaert, R. Limiting inflammation-the negative regulation of NF-kappaB and the NLRP3 inflammasome. Nat. Immunol. 18, 861\u2013869 (2017).","journal-title":"Nat. Immunol."},{"key":"22987_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"FX Yu","year":"2015","unstructured":"Yu, F. X., Zhao, B. & Guan, K. L. Hippo Pathway in organ size control, tissue homeostasis, and cancer. Cell 163, 811\u2013828 (2015).","journal-title":"Cell"},{"key":"22987_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","volume":"19","author":"D Pan","year":"2010","unstructured":"Pan, D. The hippo signaling pathway in development and cancer. Dev. Cell 19, 491\u2013505 (2010).","journal-title":"Dev. Cell"},{"key":"22987_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/abbs\/gmu109","volume":"47","author":"B Mao","year":"2015","unstructured":"Mao, B., Gao, Y., Bai, Y. & Yuan, Z. Hippo signaling in stress response and homeostasis maintenance. Acta Biochim. Biophys. Sin. 47, 2\u20139 (2015).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"22987_CR11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.cell.2015.12.029","volume":"164","author":"B Liu","year":"2016","unstructured":"Liu, B. et al. Toll receptor-mediated hippo signaling controls innate immunity in Drosophila. Cell 164, 406\u2013419 (2016).","journal-title":"Cell"},{"key":"22987_CR12","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni.3268","volume":"16","author":"J Geng","year":"2015","unstructured":"Geng, J. et al. Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity. Nat. Immunol. 16, 1142\u20131152 (2015).","journal-title":"Nat. Immunol."},{"key":"22987_CR13","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1172\/JCI81203","volume":"125","author":"W Li","year":"2015","unstructured":"Li, W. et al. STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma. J. Clin. Investig. 125, 4239\u20134254 (2015).","journal-title":"J. Clin. Investig."},{"key":"22987_CR14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ni.3744","volume":"18","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKKvarepsilon-mediated phosphorylation. Nat. Immunol. 18, 733\u2013743 (2017).","journal-title":"Nat. Immunol."},{"key":"22987_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/ncb3496","volume":"19","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q. et al. Hippo signalling governs cytosolic nucleic acid sensing through YAP\/TAZ-mediated TBK1 blockade. Nat. Cell Biol. 19, 362\u2013374 (2017).","journal-title":"Nat. Cell Biol."},{"key":"22987_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nature20602","volume":"540","author":"L Wang","year":"2016","unstructured":"Wang, L. et al. Integrin-YAP\/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow. Nature 540, 579\u2013582 (2016).","journal-title":"Nature"},{"key":"22987_CR17","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.celrep.2019.03.028","volume":"27","author":"X Zhou","year":"2019","unstructured":"Zhou, X. et al. YAP aggravates inflammatory bowel disease by regulating M1\/M2 macrophage polarization and gut microbial homeostasis. Cell Rep. 27, 1176\u20131189 e1175 (2019).","journal-title":"Cell Rep."},{"key":"22987_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCRESAHA.118.313143","volume":"123","author":"Y Lv","year":"2018","unstructured":"Lv, Y. et al. YAP controls endothelial activation and vascular inflammation through TRAF6. Circ. Res. 123, 43\u201356 (2018).","journal-title":"Circ. Res"},{"key":"22987_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep16759","volume":"5","author":"S Morvaridi","year":"2015","unstructured":"Morvaridi, S., Dhall, D., Greene, M. I., Pandol, S. J. & Wang, Q. Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis. Sci. Rep. 5, 16759 (2015).","journal-title":"Sci. Rep."},{"key":"22987_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.devcel.2010.06.015","volume":"19","author":"N Zhang","year":"2010","unstructured":"Zhang, N. et al. The Merlin\/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev. Cell 19, 27\u201338 (2010).","journal-title":"Dev. Cell"},{"key":"22987_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature10558","volume":"479","author":"N Kayagaki","year":"2011","unstructured":"Kayagaki, N. et al. Non-canonical inflammasome activation targets caspase-11. Nature 479, 117\u2013121 (2011).","journal-title":"Nature"},{"key":"22987_CR22","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1101\/gad.264234.115","volume":"29","author":"Q Chen","year":"2015","unstructured":"Chen, Q. et al. Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP. Genes Dev. 29, 1285\u20131297 (2015).","journal-title":"Genes Dev."},{"key":"22987_CR23","doi-asserted-by":"publisher","first-page":"13839","DOI":"10.1073\/pnas.1313192110","volume":"110","author":"M Xin","year":"2013","unstructured":"Xin, M. et al. Hippo pathway effector Yap promotes cardiac regeneration. Proc. Natl Acad. Sci. USA 110, 13839\u201313844 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"22987_CR24","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","volume":"150","author":"FX Yu","year":"2012","unstructured":"Yu, F. X. et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780\u2013791 (2012).","journal-title":"Cell"},{"key":"22987_CR25","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1101\/gad.197582.112","volume":"26","author":"JS Mo","year":"2012","unstructured":"Mo, J. S., Yu, F. X., Gong, R., Brown, J. H. & Guan, K. L. Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs). Genes Dev. 26, 2138\u20132143 (2012).","journal-title":"Genes Dev."},{"key":"22987_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri3111","volume":"12","author":"X Jiang","year":"2011","unstructured":"Jiang, X. & Chen, Z. J. The role of ubiquitylation in immune defence and pathogen evasion. Nat. Rev. Immunol. 12, 35\u201348 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"22987_CR27","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1158\/0008-5472.CAN-10-2518","volume":"71","author":"CH Su","year":"2011","unstructured":"Su, C. H. et al. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability. Cancer Res. 71, 884\u2013894 (2011).","journal-title":"Cancer Res."},{"key":"22987_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8530","volume":"6","author":"L Phan","year":"2015","unstructured":"Phan, L. et al. The cell cycle regulator 14-3-3\u03c3 opposes and reverses cancer metabolic reprogramming. Nat. Commun. 6, 7530 (2015).","journal-title":"Nat. Commun."},{"key":"22987_CR29","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1101\/gad.1909210","volume":"24","author":"B Zhao","year":"2010","unstructured":"Zhao, B., Li, L., Lei, Q. & Guan, K. L. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 24, 862\u2013874 (2010).","journal-title":"Genes Dev."},{"key":"22987_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/ncb2303","volume":"13","author":"B Zhao","year":"2011","unstructured":"Zhao, B., Tumaneng, K. & Guan, K. L. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat. Cell Biol. 13, 877\u2013883 (2011).","journal-title":"Nat. Cell Biol."},{"key":"22987_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1101\/gad.1843810","volume":"24","author":"B Zhao","year":"2010","unstructured":"Zhao, B., Li, L., Tumaneng, K., Wang, C. Y. & Guan, K. L. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(\u03b2-TRCP). Genes Dev. 24, 72\u201385 (2010).","journal-title":"Genes Dev."},{"key":"22987_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","volume":"88","author":"S Ma","year":"2019","unstructured":"Ma, S., Meng, Z., Chen, R. & Guan, K. L. The Hippo pathway: biology and pathophysiology. Annu. Rev. Biochem. 88, 577\u2013604 (2019).","journal-title":"Annu. Rev. Biochem."},{"key":"22987_CR33","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.3389\/fimmu.2018.02930","volume":"9","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. \u03b2-TrCP restricts lipopolysaccharide (LPS)-induced activation of TRAF6-IKK pathway upstream of I\u03baB\u03b1 signaling. Front. Immunol. 9, 2930 (2018).","journal-title":"Front. Immunol."},{"key":"22987_CR34","doi-asserted-by":"publisher","unstructured":"Bi, Y., Cui, D., Xiong X. & Zhao Y. The characteristics and roles of \u03b2-TrCP1\/2 in carcinogenesis. FEBS J. https:\/\/doi.org\/10.1111\/febs.15585 (2020).","DOI":"10.1111\/febs.15585"},{"key":"22987_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y Yan","year":"2015","unstructured":"Yan, Y. et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell 160, 62\u201373 (2015).","journal-title":"Cell"},{"key":"22987_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.molcel.2017.08.017","volume":"68","author":"N Song","year":"2017","unstructured":"Song, N. et al. NLRP3 phosphorylation is an essential priming event for inflammasome activation. Mol. Cell 68, 185\u2013197.e186 (2017).","journal-title":"Mol. Cell"},{"key":"22987_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.tibs.2017.11.009","volume":"43","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., Zhang, H. & Zhao, B. Hippo signaling in the immune system. Trends Biochem. Sci. 43, 77\u201380 (2018).","journal-title":"Trends Biochem. Sci."},{"key":"22987_CR38","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s41423-018-0007-1","volume":"15","author":"L Hong","year":"2018","unstructured":"Hong, L., Li, X., Zhou, D., Geng, J. & Chen, L. Role of Hippo signaling in regulating immunity. Cell. Mol. Immunol. 15, 1003\u20131009 (2018).","journal-title":"Cell. Mol. Immunol."},{"key":"22987_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.atherosclerosis.2017.10.027","volume":"267","author":"M Baldrighi","year":"2017","unstructured":"Baldrighi, M., Mallat, Z. & Li, X. NLRP3 inflammasome pathways in atherosclerosis. Atherosclerosis 267, 127\u2013138 (2017).","journal-title":"Atherosclerosis"},{"key":"22987_CR40","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","volume":"126","author":"A Abbate","year":"2020","unstructured":"Abbate, A. et al. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circ. Res. 126, 1260\u20131280 (2020).","journal-title":"Circ. Res."},{"key":"22987_CR41","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2337\/db12-0420","volume":"62","author":"HM Lee","year":"2013","unstructured":"Lee, H. M. et al. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes 62, 194\u2013204 (2013).","journal-title":"Diabetes"},{"key":"22987_CR42","doi-asserted-by":"publisher","first-page":"110542","DOI":"10.1016\/j.biopha.2020.110542","volume":"130","author":"Z Li","year":"2020","unstructured":"Li, Z., Guo, J. & Bi, L. Role of the NLRP3 inflammasome in autoimmune diseases. Biomed. Pharmacother. 130, 110542 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"22987_CR43","doi-asserted-by":"publisher","first-page":"107990","DOI":"10.1016\/j.celrep.2020.107990","volume":"32","author":"M Liu","year":"2020","unstructured":"Liu, M. et al. Macrophage K63-linked ubiquitination of YAP promotes its nuclear localization and exacerbates atherosclerosis. Cell Rep. 32, 107990 (2020).","journal-title":"Cell Rep."},{"key":"22987_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41586-019-1485-8","volume":"573","author":"AG Solis","year":"2019","unstructured":"Solis, A. G. et al. Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity. Nature 573, 69\u201374 (2019).","journal-title":"Nature"},{"key":"22987_CR45","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3389\/fimmu.2018.01054","volume":"9","author":"DW Shim","year":"2018","unstructured":"Shim, D. W. & Lee, K. H. Posttranslational regulation of the NLR family pyrin domain-containing 3 inflammasome. Front. Immunol. 9, 1054 (2018).","journal-title":"Front. Immunol."},{"key":"22987_CR46","doi-asserted-by":"publisher","first-page":"16079","DOI":"10.1073\/pnas.1306556110","volume":"110","author":"SY Chuang","year":"2013","unstructured":"Chuang, S. Y. et al. TLR-induced PAI-2 expression suppresses IL-1beta processing via increasing autophagy and NLRP3 degradation. Proc. Natl Acad. Sci. USA 110, 16079\u201316084 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"22987_CR47","doi-asserted-by":"publisher","first-page":"18124","DOI":"10.1074\/jbc.M115.645549","volume":"290","author":"S Han","year":"2015","unstructured":"Han, S. et al. Lipopolysaccharide primes the NALP3 inflammasome by inhibiting its ubiquitination and degradation mediated by the SCFFBXL2 E3 ligase. J. Biol. Chem. 290, 18124\u201318133 (2015).","journal-title":"J. Biol. Chem."},{"key":"22987_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13727","volume":"7","author":"H Song","year":"2016","unstructured":"Song, H. et al. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat. Commun. 7, 13727 (2016).","journal-title":"Nat. Commun."},{"key":"22987_CR49","doi-asserted-by":"crossref","unstructured":"Tang, J. et al. Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia. J. Exp. Med. 217, e20182091 (2020).","DOI":"10.1084\/jem.20182091"},{"key":"22987_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.molcel.2012.11.009","volume":"49","author":"BF Py","year":"2013","unstructured":"Py, B. F., Kim, M. S., Vakifahmetoglu-Norberg, H. & Yuan, J. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol. Cell 49, 331\u2013338 (2013).","journal-title":"Mol. Cell"},{"key":"22987_CR51","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2010.12.007","volume":"33","author":"BA Malynn","year":"2010","unstructured":"Malynn, B. A. & Ma, A. Ubiquitin makes its mark on immune regulation. Immunity 33, 843\u2013852 (2010).","journal-title":"Immunity"},{"key":"22987_CR52","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/35056563","volume":"2","author":"AM Weissman","year":"2001","unstructured":"Weissman, A. M. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2, 169\u2013178 (2001).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"22987_CR53","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.molcel.2017.09.005","volume":"68","author":"S Jin","year":"2017","unstructured":"Jin, S. et al. Tetherin suppresses type i interferon signaling by targeting MAVS for NDP52-mediated selective autophagic degradation in human cells. Mol. Cell 68, 308\u2013322.e304 (2017).","journal-title":"Mol. Cell"},{"key":"22987_CR54","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.celrep.2017.10.020","volume":"21","author":"C Zhao","year":"2017","unstructured":"Zhao, C. et al. The E3 ubiquitin ligase TRIM40 attenuates antiviral immune responses by targeting MDA5 and RIG-I. Cell Rep. 21, 1613\u20131623 (2017).","journal-title":"Cell Rep."},{"key":"22987_CR55","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/ncb2006","volume":"12","author":"H Ashida","year":"2010","unstructured":"Ashida, H. et al. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO\/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nat. Cell Biol. 12, 66\u201373 (2010). sup pp 61\u201369.","journal-title":"Nat. Cell Biol."},{"key":"22987_CR56","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1038\/sj.onc.1207389","volume":"23","author":"SY Fuchs","year":"2004","unstructured":"Fuchs, S. Y., Spiegelman, V. S. & Kumar, K. G. The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer. Oncogene 23, 2028\u20132036 (2004).","journal-title":"Oncogene"},{"key":"22987_CR57","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","volume":"45","author":"C Guo","year":"2016","unstructured":"Guo, C. et al. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity 45, 802\u2013816 (2016).","journal-title":"Immunity"},{"key":"22987_CR58","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/ni.3538","volume":"17","author":"L Mortimer","year":"2016","unstructured":"Mortimer, L., Moreau, F., MacDonald, J. A. & Chadee, K. NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations. Nat. Immunol. 17, 1176\u20131186 (2016).","journal-title":"Nat. Immunol."},{"key":"22987_CR59","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1084\/jem.20162040","volume":"214","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z. et al. Protein kinase D at the Golgi controls NLRP3 inflammasome activation. J. Exp. Med. 214, 2671\u20132693 (2017).","journal-title":"J. Exp. Med."},{"key":"22987_CR60","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.4049\/jimmunol.2000649","volume":"205","author":"W Zhao","year":"2020","unstructured":"Zhao, W. et al. AKT regulates NLRP3 inflammasome activation by phosphorylating nlrp3 serine 5. J. Immunol. (Baltim., Md: 1950) 205, 2255\u20132264 (2020).","journal-title":"J. Immunol. (Baltim., Md: 1950)"},{"key":"22987_CR61","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1002\/art.21050","volume":"52","author":"I J\u00e9ru","year":"2005","unstructured":"J\u00e9ru, I. et al. Interaction of pyrin with 14.3.3 in an isoform-specific and phosphorylation-dependent manner regulates its translocation to the nucleus. Arthritis Rheum. 52, 1848\u20131857 (2005).","journal-title":"Arthritis Rheum."},{"key":"22987_CR62","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/ni.3457","volume":"17","author":"YH Park","year":"2016","unstructured":"Park, Y. H., Wood, G., Kastner, D. L. & Chae, J. J. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat. Immunol. 17, 914\u2013921 (2016).","journal-title":"Nat. Immunol."},{"key":"22987_CR63","doi-asserted-by":"crossref","unstructured":"Shi, H., Murray, A. & Beutler, B. Reconstruction of the mouse inflammasome system in HEK293T cells. Bio Protoc. 6, e1986 (2016).","DOI":"10.21769\/BioProtoc.1986"},{"key":"22987_CR64","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22987-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22987-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22987-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T06:59:00Z","timestamp":1669964340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22987-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["22987"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-22987-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,11]]},"assertion":[{"value":"31 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2674"}}